CELL SIGNALING TECHNOLOGY, INC.

Cell Signaling Technology, Inc. specializes in the development and delivery of high-specificity antibodies and reagents for Western blot analysis, alongside advanced proteomic profiling services including global TMT quantification. The company provides precise molecular detection tools critical for life science research, with deep expertise in phosphoprotein analysis, signal transduction pathway characterization, and analytical assay validation. Their technical capabilities center on antibody conjugation, epitope mapping, and standardized reagent production for reproducible experimental outcomes in academic and government research environments. A key differentiator lies in their ability to bridge molecular biology with analytical instrumentation, as demonstrated by their work in manufacturing and servicing specialized laboratory instruments for phospho-proteomic applications. The contractor has established a consistent relationship with the Department of Health and Human Services, delivering mission-critical research reagents and analytical services that support biomedical discovery and public health surveillance. Their engagements with HHS focus on enabling precise, scalable protein detection workflows essential for translational research, immunology studies, and biomarker identification programs. Primary industry focus is in research and development within the life sciences, particularly in biochemical and molecular analysis domains excluded from nanotechnology and biotechnology classifications. The company also maintains niche expertise in analytical laboratory instrument manufacturing, positioning them as a specialized provider of precision tools for proteomics and post-translational modification analysis. Cell Signaling Technology, Inc. is a small business structured as a 2L entity, headquartered in Danvers, Massachusetts. While currently holding no formal government certifications, their technical rigor and focus on reproducibility in life science reagents establish a strong reputation within federal research ecosystems. Their geographic presence and operational focus align with the concentrated biotech and academic research hubs of the Northeastern U.S., serving federal agencies requiring high-fidelity molecular detection solutions.